Can an Early Blood Test Help Predict Vision After MS?

Credibility

Interest

Share:2 min read

Key Takeaway

After a first episode of optic neuritis, a blood test taken early on may help predict who will have more lasting eye nerve damage and trouble seeing faint letters.

What They Found

Researchers followed 51 people for about two years after their first episode of optic neuritis, an eye nerve problem that can happen with MS. They measured a substance in the blood that rises when nerve fibers are injured. People with higher levels early on tended to have more thinning in parts of the affected eye that carry visual signals, like worn-down wiring. They also tended to have more trouble reading faint, low-contrast letters, which can be harder to see than dark letters on a white page. The blood test did not predict how well people read high-contrast letters.

Who Should Care and Why

This study matters to people with MS who develop optic neuritis, as well as their caregivers and eye care teams. Vision may seem better on a standard eye chart even when faint letters are still hard to see. If you have optic neuritis, tell your care team about trouble seeing low-contrast details, not just blurry vision. You can ask whether follow-up tests of low-contrast vision and the layers at the back of the eye would help track your recovery. For now, the blood test is a possible way to identify people for future treatment studies, not a test shown here to change care.

Important Considerations

The study included only 51 people, so larger studies are needed to check how reliable the finding is. It followed people after a first episode of optic neuritis, so the results may not apply to every person with MS or every cause of vision loss. The blood test showed a link with later outcomes, but it cannot tell any one person exactly how much vision they will regain.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics Specific Symptoms MS Progression

Article Topics:

multiple sclerosisneurofilamentsoptic neuritisoptical coherence tomography

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News